![Nelson Chao](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nelson Chao
President bij American Society for Blood & Marrow Transplantation
Actieve functies van Nelson Chao
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Duke University Medical Center | Corporate Officer/Principal | - | - |
American Society for Blood & Marrow Transplantation | President | - | - |
Loopbaan van Nelson Chao
Eerdere bekende functies van Nelson Chao
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Aldagen, Inc.
![]() Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | Oprichter | 01-03-2000 | - |
Corporate Officer/Principal | 01-03-2000 | 29-10-2009 | |
Bedrijfssecretaris | 06-11-2009 | - |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Corporate Officer/Principal | 2 |
Founder | 1 |
Corporate Secretary | 1 |
Sectoraal
Health Technology | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Aldagen, Inc.
![]() Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | Health Technology |
American Society for Blood & Marrow Transplantation |
- Beurs
- Insiders
- Nelson Chao
- Ervaring